Health Care & Life Sciences » Biotechnology | Japan Tissue Engineering Co. Ltd.

Japan Tissue Engineering Co. Ltd. | Balance Sheet

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
Cash & Short Term Investments
1,307
5,966
3,854
4,090
6,404
Total Accounts Receivable
469
404
454
833
591
Inventories
107
138
123
119
138
Other Current Assets
30
165
70
28
161
Total Current Assets
1,914
6,673
4,502
5,070
7,294
Net Property, Plant & Equipment
1,261
1,698
1,822
1,725
1,656
Total Investments and Advances
-
-
400
1,900
1,700
Intangible Assets
48
48
49
38
23
Other Assets
10
34
25
13
50
Total Assets
3,233
8,853
8,297
8,546
9,023
ST Debt & Current Portion LT Debt
125
8
8
7
5
Accounts Payable
104
39
56
49
74
Income Tax Payable
18
33
31
44
36
Other Current Liabilities
294
266
395
399
619
Total Current Liabilities
541
346
490
498
734
Long-Term Debt
437
19
15
8
3
Provision for Risks & Charges
91
91
74
35
35
Total Liabilities
1,069
456
578
541
772
Common Equity (Total)
2,163
8,397
7,718
8,005
8,251
Total Shareholders' Equity
2,163
8,397
7,718
8,005
8,251
Total Equity
2,163
8,397
7,718
8,005
8,251
Liabilities & Shareholders' Equity
3,233
8,853
8,297
8,546
9,023

About Japan Tissue Engineering Co.

View Profile
Address
6-209-1 Miyakitadori
Gamagori Aichi 443
Japan
Employees -
Website http://www.jpte.co.jp
Updated 09/14/2018
Japan Tissue Engineering Co., Ltd. engages in the research, development, and manufacture of cultured biological cells and tissues. It operates through the Regenerative Medicine, Custom Development and Manufacturing, and Research and Development (R&D) Support segments. The Regenerative Medicine segment develops, manufactures, and sells tissue-engineered medical products through autologous culturing techniques.